US Patent 11840572 Therapeutic antibodies and their uses
Patent 11840572 was granted and assigned to Pfizer on December, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 16, 2021
0
Date of Patent
December 12, 2023
0
Patent Applicant
Patent Application Number
17378377
0
Patent Inventor Names
Lei Wu
0
Andrea Therese Hooper
0
Malgorzata Agnieszka Nocula-Lugowska
0
James Reasoner Apgar
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11840572 Therapeutic antibodies and their uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.